BARD1 ^None

BARD1 is a protein released by cancer cells that can be used to diagnose lung cancer. BARD1AG is developing a non-invasive test that uses BARD1 antibodies and RNA splice-variants. The test involves an ELISA-based screening to detect anti-BARD1 antibodies in serum, followed by an analysis of BARD1 isoforms-specific RNA in circulating tumour cells for final diagnosis. Both tests are expected to be CE-marked by fall 2013. The test requires a small blood sample, and if positive, a second, larger sample will be needed for a definitive diagnosis.